Fusion Fuel Green 株価情報 (NASDAQ: HTOOW)

最新ニュース Fusion Fuel Green (NASDAQ:HTOOW) 株価情報

Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.

Fusion Fuel Green PLC

WIIM

SAGT

SAGT stock has given up its prior gain. SAGTEC GLOBAL shares were trading higher after the company announced the commercial launch of its AI-powered robotics platform.

Thoma Bravo has raised $34.4 billion across three funds, marking one of the largest fundraising hauls in <a href="https://www.benzinga.com/topic/private-equity-0">recent private equity history</a>.
What Happened: According <a href="https://www.wsj.com/finance/investing/thoma-bravos-34-billion-fundraising-haul-bucks-private-equity-slowdown-dd33bb56?mod=hp_lead_pos5">to</a> the Wall Street Journal, the investment giant secured $24.3 billion for its flagship buyout fund. The effort matches its 2022 total and sets the record for the largest global private-equity fund closed in 2024 or 2025. 
Blackstone previously raised $21 billion fund and EQT secured a $23.7 billion vehicle.
Thoma Bravo also raised $8.1 billion for its Discover fund, which targets midsize software companies. That&#8217;s up from $6.2 billion in 2022. 
The firm, which specializes in software, is currently shopping around Denver-based Apryse. Lazard is <a href="https://www.benzinga.com/markets/asset-sales/25/05/45702349/deal-dispatch-beauty-brand-behavioral-health-firms-hit-auction-block">managing the sale process</a>. 
See Also: <a href="https://www.benzinga.com/markets/small-cap/25/06/45743618/exclusive-vivakor-bets-on-permian-boom-with-10-crude-hubs">EXCLUSIVE &#8211; Vivakor Bets On Permian Boom With 10 Crude Hubs</a>
Why It Matters: Thoma Bravo's success exemplifies how limited partners view the firm as a safe bet in the face of regulatory uncertainty.
The company completed its efforts within the typical one-year period, whereas its rivals are taking much longer.
Meanwhile, the broader private equity landscape is in a rut. According to a March <a href="https://www.bain.com/insights/outlook-is-a-recovery-starting-to-take-shape-global-private-equity-report-2025/" target="_blank" rel="noopener">report by Bain &amp; Co.</a>, firms are sitting on a record 29,000 companies valued at $3.6 trillion, half of which have been held for five years or more.
Many were acquired before the Federal Reserve began raising interest rates in 2022, complicating exit strategies and depressing valuations. 
Basically, it&#8217;s a challenging fundraising climate as none of the buyout funds that closed in the first quarter of 2025 exceeded $5 billion, Bain explained. That&#8217;s something not seen in over a decade.
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/futures/25/06/45740778/us-stocks-likely-to-open-lower-expert-highlights-technical-analysis-showing-sp-500s-recovery-is-real-and-not-a-bull-trap-or-bear-market-rally">US Stocks Likely To Open Lower: Expert Highlights Technical Analysis Showing S&amp;P 500&#8217;s &#8216;Recovery Is Real&#8217; And Not A &#8216;Bull Trap&#8217; Or &#8216;Bear Market Rally&#8217;</a></li>
</ul>
Image: Shutterstock

Financing

Thoma Bravo Raises $34.4 Billion, Setting A Private-Equity Record: Report

AMZE

Amaze Holdings shares are trading lower after the company announced it will implement a 1-for-23 reverse stock split.

News

Rumors

Trading Ideas

AAPL

GOOG

GOOGL

Watching Alphabet; Shares Trade Lower, Traders Circulate Unconfirmed Rumor That Apple Is Reportedly In Talks With Perplexity To Bring Its AI Search To iPhones; Potentially Replacing Google In Safari And ChatGPT In Siri

Wells Fargo analyst Sam Reid maintains Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) with a Overweight and lowers the price target from $130 to $125.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Toll Brothers, Lowers Price Target to $125

VERO

Venus Concept shares are trading lower after the company announced it reached an agreement with Madryn Health to waive certain loan agreements for liquidity relief.

<ul>
<li>While Epogen and Neupogen addresses anemia and neutropenia, no therapy has existed for the treatment of lymphopenia until ANKTIVA&#xAE; –The Cancer BioShield.</li>
<li>Landmark overall survival benefit (P-value 0.005, HR: 0.46 [0.26, 0.80]) observed in 3rd-6th line metastatic pancreatic cancer, correlated with reversal of lymphopenia.</li>
<li>Patients with lower tumor burden and improved lymphocyte counts (ALC ≥1,000) had a median overall survival of 10.1 months, supporting earlier intervention in the disease course.</li>
</ul>
ImmunityBio, Inc. ((<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;,%20url=https%3A%2F%2Fwww.nasdaq.com%2Fmarket-activity%2Fstocks%2Fibrx&amp;,%20esheet=54264184&amp;,%20newsitemid=20250603288322&amp;,%20lan=en-US&amp;,%20anchor=NASDAQ%3A+IBRX&amp;,%20index=1&amp;,%20NASDAQ:%3Ca%20class=">IBRX</a>) today announced results presented at ASCO 2025 of the first known treatment for lymphopenia with ANKTIVA and CAR-NK therapy. This data supports that reversal of lymphopenia, a well-established root cause of early mortality in patients with cancer across all tumor types, correlates with significant improved survival.
While anemia and neutropenia have long been addressed by agents like Epogen and Neupogen, no therapy has ever existed for lymphopenia—until now. ANKTIVA (nogapendekin alfa inbakicept-pmln), an IL-15 superagonist approved in April 2024 for BCG-unresponsive non-muscle- invasive bladder cancer carcinoma in situ with or without papillary disease, represents the first lymphocyte-stimulating agent (LSA) capable of expanding lymphocytes critical for immunogenic cell death, such as natural killer (NK) and T cells.

ImmunityBio Presents ANKTIVA And CAR-NK Therapy Data At ASCO 2025, Advancing Lymphopenia Treatment

Billionaire investor Ray Dalio&#8217;s Bridgewater Associates is planning to accumulate funding for an Asia-excluding-China fund that caters to Chinese investors looking to diversify their holdings across the Asian economy.
What Happened: Bridgewater&#8217;s Chinese arm is looking to raise funds for its new product, which plans to invest in the Asia ex-China Total Return Fund, which has returned 20.7% on an annualized basis since its inception in October 2023, according to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-06-03/bridgewater-taps-china-s-wealthy-with-a-21-return-asia-strategy?taid=683eabb92e9f3e0001063aaf&amp;utm_campaign=trueanthem&amp;utm_content=business&amp;utm_medium=social&amp;utm_source=twitter">report</a>. 
The firm founded by Dalio increased its onshore assets under management in China by 40% to $7.6 billion, or 55 billion yuan, in 2024. This was boosted by the firm&#8217;s multi-asset strategy fund, which outperformed many local rivals.
The Asia strategy fund achieved a 14% return before fees in the first four months of 2025, with 5.3% attributed to active management.
Since its inception, the fund has delivered an annualized return of 20.7%, outperforming the company&#8217;s All Weather Plus onshore China strategy, which had an annualized return of 19.4% through April 30, 2018. The onshore China strategy itself gained 10.9% year-to-date through April.
See Also:<a href="https://www.benzinga.com/markets/equities/25/06/45739065/sp-500-reverses-short-term-downtrend-after-april-lows-technical-evidence-shows-recovery-is-real-and-not-a-bull-trap-or-bear-market-rally"> S&amp;P 500 Reverses Short-Term Downtrend After April Lows: Technical Evidence Shows &#8216;Recovery Is Real&#8217; And Not A &#8216;Bull Trap&#8217; Or &#8216;Bear Market Rally&#8217;</a>
Why It Matters: While Bridgewater expands in China, Dalio has appreciated <a href="https://www.benzinga.com/general/market-summary/25/03/44273552/ray-dalio-says-china-is-way-ahead-in-ai-and-robotics-us-lags-in-mass-production">China&#8217;s dominance in the application</a> and usage of artificial intelligence technology during several public appearances. 
During his speech at CNBC&#8217;s Converge Live in Singapore, Dalio underscored the United States&#8217; distinct advantage in innovation, particularly in developing &#8220;the best chips in the world.&#8221;
However, he pointed out that the U.S. lags in its mass production. Regarding China, Dalio stated, &#8220;China is behind but not by a lot in the best chips,&#8221; and elaborated that the Asian nation leads in chip volume production and in integrating those chips into various applications.
He further emphasized China&#8217;s lead in practical applications, stating, &#8220;They are ahead on the applications, and they are integrating chips with robotics, and way ahead on that.&#8221; Dalio concluded by noting that application and usage would be significant competitive factors in the future.
Dalio had brought up the same points while speaking with David Friedberg on the<a href="https://www.benzinga.com/government/regulations/25/02/43431874/billionaire-ray-dalio-raises-valuation-concerns-as-deepseeks-new-model-hits-nvidia-stock-a-great-company-that-gets-expensive-is-much-worse-than-a-bad-company-thats-really-cheap"> All-In Podcast</a> in late January. &#8220;I think the Chinese are a bit behind in the chips, but they are ahead in the applications,&#8221; he said in the podcast. 
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Tuesday. The SPY was down 0.17% at $591.71, while the QQQ declined 0.04% to $523.00, according to Benzinga Pro data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/06/45716143/trump-administration-set-to-ease-big-bank-rules-in-major-rollback-since-2008-crisis-here-are-the-stocks-and-etfs-investors-could-consider" target="_blank" rel="noreferrer noopener">Trump Administration Set To Ease Big Bank Rules In Major Rollback Since 2008 Crisis: Here Are The Stocks And ETFs Investors Could Consider</a></li>
</ul>
Image via Shutterstock

Markets

Billionaire Investor Ray Dalio's Bridgewater Bets Big On Asia—But Snubs China In New $7.6 Billion Push

Wells Fargo analyst Sam Reid maintains KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) with a Underweight and lowers the price target from $55 to $53.

Wells Fargo Maintains Underweight on KB Home, Lowers Price Target to $53

Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) ("Titan" or the "Company") announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission ("SEC") of a registration statement on Form F-4 in connection with the proposed combination of Titan and TalenTec Sdn. Bhd. (f/k/a KE Sdn. Bhd.) ("TalenTec"), which includes Titan's preliminary proxy statement (the "Form F-4")
As previously announced on August 19, 2024, Titan and TalenTec have entered into a Merger and Contribution and Share Exchange Agreement (the "Merger Agreement") regarding a business combination, pursuant to which Titan will be combined with TalenTec in a "reverse merger" transaction (the "Business Combination").
The Form F-4 was filed by Black Titan Corporation, the holding company under which the businesses will combine, and is available through the SEC's website at&nbsp;<a href="https://www.globenewswire.com/Tracker?data=FFrMd0mDvYP8cXX12hfkXBOfMSwbHvOdLx_TfcN_6ptkZNH0pmhInSa_3PQdDWxsvkbUZs4bF5pMgEr0zvcpJA==">www.sec.gov</a>&nbsp;under the name "Black Titan Corporation." The registration statement has not been declared effective by the SEC and the information in the preliminary proxy statement/prospectus is not complete and may be changed.
The Business Combination is subject to approval by Titan stockholders and the satisfaction of other customary closing conditions and is expected to close in the third quarter of 2025 although there can be no assurance thereof.
Important Information About the Business Combination and Where to Find It
This communication is being made in respect of the proposed Business Combination transaction between Titan and TalenTec. The proposed transaction will be submitted to the stockholders of Titan for their consideration and approval. In connection with the proposed transaction, Black Titan Corporation has filed with the SEC a registration statement on Form F-4 that includes a preliminary proxy statement/prospectus (a "Proxy Statement/Prospectus"). After the registration statement has been declared effective by the SEC, a definitive Proxy Statement/Prospectus will be mailed to Titan's stockholders as of a record date to be established by Titan's board of directors for voting on the Business Combination. Titan may also file other relevant documents regarding the Business Combination with the SEC. Titan's stockholders and other interested persons are advised to read, once available, the preliminary Proxy Statement/Prospectus and any amendments thereto and, once available, the definitive Proxy Statement/Prospectus, in connection with Titan's solicitation of proxies for its special meeting of stockholders to be held to approve, among other things, the Business Combination, because these documents will contain important information about Titan, TalenTec and the Business Combination. Stockholders of Titan may also obtain a copy of the preliminary or definitive proxy statement, once available, as well as other documents filed with the SEC regarding the Business Combination and other documents filed with the SEC, without charge, at the SEC's website located at <a href="http://www.sec.gov/">www.sec.gov</a> or by directing a request to: Titan's Chief Executive Officer at 10 East 53rd St., Suite 3001, New York, NY 10022.

Biotech

General

TTNP

Titan Pharmaceuticals Announces Filing By Black Titan Corporation With SEC For Previously Announced Proposed Combination Of Titan And TalenTec

Watching Alphabet; Shares Sink -1.9% To New Premarket Low

Wells Fargo analyst Gabe Hajde maintains Greif (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEF#NYSE">GEF</a>) with a Overweight and lowers the price target from $75 to $67.

Wells Fargo Maintains Overweight on Greif, Lowers Price Target to $67

Energi Holdings proposes to acquire 51% of Tembo based on a total enterprise value of US$200 million
Parties now agree to work towards negotiating binding transaction documents with a view to early closing
Board concurrently evaluating special dividends and/or capital return to shareholders
&nbsp;

VVPR

VivoPower Advances $200M Tembo Transaction After Completing Second Phase Of Due Diligence By Energi Holdings

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4440857-1&amp;h=3230044016&amp;u=https%3A%2F%2Fwww.rbbn.com%2F&amp;a=Ribbon+Communications+Inc.">Ribbon Communications Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>), a leading supplier of real-time communications technology and IP optical networking solutions, announced that its Board of Directors has authorized a program to repurchase up to&nbsp;$50 million&nbsp;of the Company's common stock, commencing June 5, 2025 and continuing through December 31, 2027.
"Today's announcement of our new share repurchase program reflects the Board of Director's confidence in our strategic plan and the significant improvement in our performance, highlighted by the record financial results in the fourth quarter 2024. Business with US Tier One Service Providers doubled in 2024 underpinned by a multi-year contract with Verizon to support modernizing their telecom voice infrastructure along with projects with other carriers. At the same time, business with Enterprise customers and U.S. Federal agencies has grown significantly. Overall, earnings increased by 30% in 2024 and were at the high end of our original guidance for the year," said Bruce&nbsp;McClelland, President and CEO of Ribbon Communications.&nbsp; "The visibility in our business has improved significantly with positive book-to-bill and growing backlog, and we are focused on driving profitable growth and strong cash flow generation. This share repurchase program exemplifies our commitment to deliver value to our stockholders."

Buybacks

RBBN

Ribbon Announces $50M Share Repurchase Program Starting On June 5, 2025

Wells Fargo analyst Stephen Baxter maintains Pennant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNTG#NASDAQ">PNTG</a>) with a Equal-Weight and raises the price target from $30 to $31.

PNTG

Wells Fargo Maintains Equal-Weight on Pennant Gr, Raises Price Target to $31

KAPA

Kairos Pharma shares are trading lower. The company presented data on its GITR ligand agonist KROS101 at ASCO 2025.

Wells Fargo analyst Stephen Baxter maintains McKesson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) with a Equal-Weight and raises the price target from $691 to $766.

Wells Fargo Maintains Equal-Weight on McKesson, Raises Price Target to $766

CTRN

Citi Trends shares are trading higher after the company reported better-than-expected Q1 financial results.

<a href="https://www.livemint.com/companies/news/tesla-india-tesla-mumbai-lease-tesla-service-centre-india-elon-musk-lodha-logistics-park-tesla-lease-india-11748935478491.html">https://www.livemint.com/companies/news/tesla-india-tesla-mumbai-lease-tesla-service-centre-india-elon-musk-lodha-logistics-park-tesla-lease-india-11748935478491.html</a>
&nbsp;
American electric carmaker Tesla Inc. has leased 24,565 sq. ft. of space at Lodha Logistics Park in Mumbai's Kurla West. The transaction adds to the Elon Musk-promoted company's steady expansion of its real estate footprint in India—through offices, showrooms, and now warehousing—as it inches towards an expected market entry.
The five-year lease was signed between Tesla India Motor &amp; Energy Pvt. Ltd and Lodha Developers, and registered on 16 May. Tesla will pay a starting monthly rent of ₹37.53 lakh, totalling over ₹24 crore over the lease term, according to documents accessed by CRE Matrix, a real estate data analytics firm.
A person familiar with the development said the leased space may be used as a service centre for Tesla's electric vehicles. The person added that the company may expand within the facility in future.

Global

INDA

TSLA

'Tesla Leases Space In Mumbai's Lodha Logistics Park, Expanding India Footprint' - Mint

Wells Fargo analyst Jason Haas initiates coverage on ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) with a Equal-Weight rating and announces Price Target of $56.

Comments

Fusion Fuel Green

ニュース

最新ニュース Fusion Fuel Green (NASDAQ:HTOOW) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル